Oklahoma 2025 Regular Session

Oklahoma Senate Bill SB518

Introduced
2/3/25  
Refer
2/4/25  
Report Pass
2/13/25  
Engrossed
3/31/25  
Refer
4/1/25  
Refer
4/1/25  
Report Pass
4/16/25  
Enrolled
5/14/25  

Caption

Medical marijuana packaging; requiring certain warnings on labels. Effective date.

Impact

If enacted, SB518 will significantly impact how medical marijuana businesses operate. It introduces detailed protocols that businesses must follow to ensure that their products comply with state regulations concerning packaging and labeling. For instance, containers must not depict images or content aimed at individuals under the age of 21, thereby aiming to reduce the likelihood of misuse by minors. This could lead to increased costs for businesses that must adapt their packaging strategies to meet the new requirements.

Summary

Senate Bill 518 focuses on the packaging and labeling requirements for medical marijuana products in Oklahoma. The legislation aims to enhance safety and consumer awareness by imposing specific guidelines on how these products should be presented at the point of sale. Key provisions of the bill mandate that packaging must be designed to minimize appeal to children and include clear warnings about the safe use of marijuana products, reinforcing legal regulations surrounding their distribution.

Sentiment

The sentiment surrounding SB518 is generally supportive among lawmakers and health advocates, who see the bill as a necessary step toward ensuring public safety. Supporters argue that it will protect vulnerable populations, such as children, by making products less enticing and ensuring adequate warnings are provided. Conversely, some businesses might view the stipulations as overly burdensome, raising concerns about compliance costs and potential market implications.

Contention

A notable point of contention in the discussions around SB518 pertains to the balance between safeguarding public health and allowing flexibility for businesses. While supporters emphasize the importance of consumer protections, opponents express concerns about the potential financial impacts on smaller businesses that may struggle to meet the new standards. This highlights an ongoing debate about regulatory measures in the medical marijuana industry and the need for clear guidelines that consider the diverse landscape of dispensaries.

Companion Bills

No companion bills found.

Previously Filed As

OK HB3361

Medical marijuana; packaging requirements; administrative fines for violations; pre-packaged form; display and smelling of marijuana; effective date.

OK HB3335

Medical marijuana; creating the Oklahoma Medical Marijuana Act of 2024; effective date.

OK SB1979

Medical marijuana; requiring a licensed pharmacist to dispense medical marijuana. Effective date.

OK SB116

Medical marijuana; prohibiting certain medical marijuana facilities from operating in certain areas. Effective date.

OK SB116

Medical marijuana; prohibiting certain medical marijuana facilities from operating in certain areas. Effective date.

OK HB1719

Medical marijuana; creating the Medical Marijuana Act of 2023; effective date.

OK HB1717

Medical marijuana; various licensing; effective date.

OK HB1717

Medical marijuana; various licensing; effective date.

OK SB1635

Medical marijuana; requiring an affidavit for license renewal under certain circumstance; testing. Emergency.

OK SB1980

Medical marijuana; defining term; modifying definition. Effective date.

Similar Bills

HI SB704

Relating To Marijuana.

AZ HB2082

Marijuana; sampling; advertising; sale

AZ HB2770

Marijuana; interstate agreements; delivery

CT HB05458

An Act Concerning The Regulation Of The Retail Sale Of Marijuana.

AZ SB1410

Marijuana; licensing; delivery

VA HB2428

Marijuana; advertising restrictions, penalties.

VA SB1233

Marijuana; advertising restrictions, penalties.

HI HB7

Relating To Marijuana.